SUVEN

Suven Life Sciences saw a healthy rally before pulling back about 50% from ₹300 to ₹160, finding support exactly at a key trendline. It's now bouncing from what appears to be a crucial accumulation zone. The stock has tested the ₹300 level multiple times, and interestingly, previous resistance at ₹320 now seems to be acting as support. This structure, especially after a 50% pullback and successful resistance retests, suggests it's gearing up for a potential breakout and further upside in January.